Editorial: Key Players in Systemic Sclerosis: The Immune System and Beyond

Philippe Guilpain; Danièle Noël; Jérôme Avouac

doi:10.3389/fimmu.2021.770419

Editorial: Key Players in Systemic Sclerosis: The Immune System and Beyond

Front Immunol. 2021 Sep 30:12:770419. doi: 10.3389/fimmu.2021.770419. eCollection 2021.

Authors

Philippe Guilpain^{1

2

3}, Danièle Noël^{2

3}, Jérôme Avouac^{4

5

6}

Affiliations

¹ Department of Internal Medicine and Multi-Organic Diseases, Local Referral Center for Systemic and Autoimmune Diseases, St Eloi Hospital, Montpellier, France.
² Faculty of Medicine, University of Montpellier, Montpellier, France.
³ Inserm U1183, Institute for Regenerative Medicine and Biotherapy (IRMB), St Eloi Hospital, Montpellier, France.
⁴ Department of Rheumatology, Cochin Hospital, AP-HP.CUP, Paris, France.
⁵ Faculty of Medicine, University of Paris, Université Paris Descartes, Paris, France.
⁶ INSERM U1016 and CNRS UMR8104, Cochin Institute, Paris, France.

No abstract available

Keywords: abatacept; cancer; co-stimulation; extracellular vesicles; innate immune system; mesenchymal stromal cell; pathophysiology; systemic sclerosis.

Publication types

Editorial
Introductory Journal Article

MeSH terms

Animals
Cell-Derived Microparticles / immunology
Cell-Derived Microparticles / metabolism
Cytokines / immunology
Cytokines / metabolism
Humans
Immune System / cytology
Immune System / immunology*
Immune System / metabolism
Immunity, Innate / immunology*
Killer Cells, Natural / immunology
Killer Cells, Natural / metabolism
Myofibroblasts / cytology
Myofibroblasts / immunology
Scleroderma, Systemic / immunology*
Scleroderma, Systemic / metabolism
Signal Transduction / immunology*
T-Lymphocytes, Regulatory / immunology

Substances

Cytokines